Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6045267 | 0.97 | ALPL (0.36) | ALPLPOLBALPGCHRM1AKR1A1 | |
| Acetic Acid SCHEMBL3682289 | 0.95 | ALPL (0.35) | ALPLPOLBALPGCHRM1AKR1A1 | |
| Acetic Acid SCHEMBL3682298 | 0.91 | ALPL (0.41) | ALPLPOLBALPGCHRM1AKR1A1 | |
| Trifluoroacetic Acid SCHEMBL3684531 | 0.87 | ALPL (0.35) | ALPLPOLBALPG | |
| Trifluoroacetic Acid SCHEMBL3684537 | 0.83 | ALPL (0.37) | ALPLPOLBALPG | |
| SCHEMBL15610744 | 0.79 | CHRM1 (0.33) | ALPLPOLBALPGCHRM1AKR1A1 | |
| SCHEMBL5538444 | 0.79 | CHRM1 (0.50) | ALPLPOLBALPGCHRM1AKR1A1 | |
| SCHEMBL172177 | 0.78 | OR51E2 (0.39) | ALPLPOLBALPGSLC1A1GABRR1 | |
| SCHEMBL7505468 | 0.78 | OR51E2 (0.39) | ALPLPOLBALPGSLC1A1GABRR1 | |
| SCHEMBL1427298 | 0.76 | POLB (0.50) | ALPLPOLBALPGCA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4500182-A1 | PROGNOSTIC BIOMARKERS | The University of Liverpool (GB) | 2025-02-05 | — | — | EP | disclosed |
| WO-2023180753-A1 | PROGNOSTIC BIOMARKERS | THE UNIVERSITY OF LIVERPOOL (GB) | 2023-09-28 | — | — | WO | disclosed |
| US-9764069-B2 | Articles having non-fouling surfaces and processes for preparing the same including pretreatment of articles | SEMPRUS BIOSCIENCES CORPORATION (US) | 2017-09-19 | — | — | US | disclosed |
| US-9694114-B2 | Antimicrobial catheters with permeabilization agents | ARROW INTERNATIONAL, INC. (US) | 2017-07-04 | — | — | US | disclosed |
| US-20160235893-A1 | ANTIMICROBIAL CATHETERS WITH PERMEABILIZATION AGENTS | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2016-08-18 | — | — | US | disclosed |
| US-9006359-B2 | Imbibing process for contact lens surface modification | SEMPRUS BIOSCIENCES CORPORATION (US) | 2015-04-14 | — | — | US | disclosed |
| US-20150045515-A1 | NON-FOULING, ANTI-MICROBIAL, ANTI-THROMBOGENIC GRAFT-FROM COMPOSITIONS | TELEFLEX LIFE SCIENCES LIMITED (MT) | 2015-02-12 | — | — | US | disclosed |
| US-20140037967-A1 | ARTICLES HAVING NON-FOULING SURFACES AND PROCESSES FOR PREPARING THE SAME INCLUDING PRETREATMENT OF ARTICLES | SEMPRUS BIOSCIENCES CORPORATION (US) | 2014-02-06 | — | — | US | disclosed |
| CN-103497978-A | Preparation method for high-optical-purity L-carnitine | BENGBU BBCA MEDICINE SCIENCE & DEV CO LTD | 2014-01-08 | — | — | CN | disclosed |
| US-20130158518-A1 | SURFACE MODIFICATION FOR CATHETERS COMPRISED OF MULTIPLE MATERIALS | SEMPRUS BIOSCIENCES CORP. (US) | 2013-06-20 | — | — | US | disclosed |
| US-8410150-B2 | Inhibitors of carnitine palmitoyltransferase and treating cancer | UNIVERSITY HEALTH NETWORK (CA) | 2013-04-02 | — | — | US | disclosed |
| CN-102918015-A | Process for hydrochlorination of multihydroxylated aliphatic hydrocarbons | DOW GLOBAL TECHNOLOGIES LLC | 2013-02-06 | — | — | CN | disclosed |
| CN-101838212-A | Method for synthesizing L-carnitine by using (R)-(-)-3-chlorine-1,2-propylene glycol as chiral initiative raw material | UNIV SCIENCE & TECHNOLOGY BEIJING | 2010-09-22 | — | — | CN | disclosed |
| CN-101823974-A | Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine | UNIV BEIJING SCIENCE & TECH | 2010-09-08 | — | — | CN | disclosed |
| US-20100105900-A1 | INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER | UNIVERSITY HEALTH NETWORK | 2010-04-29 | — | — | US | disclosed |
| CN-1443574-A | Ranzhi Jianfei oral preparation for reducing weight | JIANG DIANSHUI (CN) | 2003-09-24 | — | — | CN | disclosed |
| EP-0711768-B1 | BENZIMIDAZOLE DERIVATIVE | MITSUI CHEMICALS INC (JP) | 2002-02-13 | — | — | EP | disclosed |
| CN-1311787-A | oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them | ASTRA ZENECA CO LTD (SE) | 2001-09-05 | — | — | CN | disclosed |
| US-5852011-A | Benzimidazole derivatives | MITSUI CHEMICALS, INC. (JP) | 1998-12-22 | — | — | US | disclosed |
| EP-0711768-A1 | BENZIMIDAZOLE DERIVATIVE | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105900-A1 | INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER | CPT1A, CPT1B, CPT2 | ALPL 2487/4885POLB 1534/4885ALPG 4032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.